What is it about?
Most of the world’s health problems afflict poor countries and their poorest inhabitants (WHO 2004). There are many reasons for this. One of these reasons is that the poor have limited access to essential drugs and technologies. The philosophical literature on pharmaceutical justice focuses, primarily, on this problem. Much of the philosophical literature, moreover, focuses on ways of dealing with the negative impacts of the World Trade Organization’s Trade Related Intellectual Property Rights (TRIPS) agreement (Hollis and Pogge 2008; Buchanan et al. 2009. For broader interdisciplinary literature on the topic, see: Abramowicz 2003; Danzon and Towse 2003; Faunce and Nasu 2008; Goodwin 2008).
Featured Image
Read the Original
This page is a summary of: Pharmaceutical Justice, January 2011, Springer Science + Business Media,
DOI: 10.1007/978-1-4020-9160-5_195.
You can read the full text:
Contributors
The following have contributed to this page
